Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure

J Physiol Sci. 2009 Jul;59(4):275-81. doi: 10.1007/s12576-009-0034-x. Epub 2009 Mar 28.

Abstract

The effects of endogenous angiotensin II (Ang II) and neuronal nitric oxide synthase (nNOS) on tonic sympathetic activity were studied in salt-sensitive hypertension-induced heart failure. Dahl salt-sensitive rats were fed 8% NaCl diet for 9 weeks to induce chronic heart failure (CHF-DSS). The effects of intravenous administration of a selective nNOS inhibitor, S-methyl-L: -thiocitrulline (SMTC), and an Ang II type 1-receptor blocker, losartan, on renal sympathetic nerve activity (RSNA) were examined in chronically instrumented conscious rats. Baroreceptor (baro)-unloaded RSNA was obtained by decreasing arterial pressure with caval occlusion to determine tonic RSNA. SMTC significantly decreased baro-unloaded RSNA, and subsequent losartan recovered baro-unloaded RSNA to the control level in CHF-DSS rats. To compare the effects of the inhibitors between low- and high-activity states of the renin-angiotensin system (RAS), Sprague-Dawley rats were fed low (0.04%)- or high (8%)-salt diets. A significant difference was found in the effects of SMTC and/or losartan on RSNA between the high- and low-RAS states, which suggested that there is a difference in the effect of endogenous Ang II on RSNA between salt-induced and other-type heart failure. To examine the effects of heart failure on brain-tissue nNOS activity, we measured the activities of the diencephalon in heart-failure rats. Heart failure significantly suppressed diencephalon nNOS activity, which was significantly different from the results in salt-sensitive hypertension without heart failure. These results suggest that endogenous Ang II has fewer effects, but nNOS has excitatory effects on tonic RSNA in salt-sensitive hypertension-induced heart failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / physiology*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Brain / enzymology
  • Citrulline / analogs & derivatives
  • Citrulline / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Heart Failure / etiology*
  • Heart Failure / physiopathology*
  • Hypertension / complications*
  • Hypertension / physiopathology*
  • Kidney / drug effects
  • Kidney / innervation*
  • Kidney / physiology
  • Losartan / pharmacology
  • Male
  • Nitric Oxide / physiology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / physiology*
  • Nitric Oxide Synthase Type I
  • Pressoreceptors / physiopathology
  • Rats
  • Rats, Inbred Dahl
  • Renin-Angiotensin System / physiology
  • Sodium Chloride, Dietary / administration & dosage
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiology
  • Thiourea / analogs & derivatives
  • Thiourea / pharmacology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Enzyme Inhibitors
  • Sodium Chloride, Dietary
  • Angiotensin II
  • Citrulline
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nos1 protein, rat
  • Thiourea
  • Losartan
  • S-methylthiocitrulline